Literature DB >> 7779552

Serum aluminum levels in Alzheimer's disease and other senile dementias.

M D Zapatero1, A Garcia de Jalon, F Pascual, M L Calvo, J Escanero, A Marro.   

Abstract

The exact cause of Alzheimer's disease and the part played in it by aluminum is still speculative. We have studied serum aluminum in 356 healthy people, and we have observed that serum aluminum concentration is increased in aging people in relation to age. We suggest that this could be associated with an enhanced gastric permeability or by an increase in metal accumulation proportional to age. We have measured serum aluminum levels in patients with probable Alzheimer's disease, patients with other senile dementias, and age-matched group. Patients with probable Alzheimer's disease have statistically significant higher serum aluminum levels than patients with other types of senile dementias (alcoholic, vascular, multi-infart) and an age-matched control group. When we compare serum aluminum of patients with senile dementias from other causes with the age-matched control group, we do not find significant differences.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779552     DOI: 10.1007/BF02790122

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  4 in total

1.  Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons.

Authors:  D P Perl; A R Brody
Journal:  Science       Date:  1980-04-18       Impact factor: 47.728

2.  Geographical relation between Alzheimer's disease and aluminum in drinking water.

Authors:  C N Martyn; D J Barker; C Osmond; E C Harris; J A Edwardson; R F Lacey
Journal:  Lancet       Date:  1989-01-14       Impact factor: 79.321

3.  Aluminosilicates and senile plaque formation in Alzheimer's disease.

Authors:  J M Candy; A E Oakley; J Klinowski; T A Carpenter; R H Perry; J R Atack; E K Perry; G Blessed; A Fairbairn; J A Edwardson
Journal:  Lancet       Date:  1986-02-15       Impact factor: 79.321

4.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

  4 in total
  6 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 2.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

Review 3.  Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.

Authors:  Maire E Percy; Theo P A Kruck; Aileen I Pogue; Walter J Lukiw
Journal:  J Inorg Biochem       Date:  2011-08-19       Impact factor: 4.155

4.  Characterization of plasma metal profiles in Alzheimer's disease using multivariate statistical analysis.

Authors:  Chunmei Guan; Rui Dang; Yu Cui; Liyan Liu; Xiaobei Chen; Xiaoyu Wang; Jingli Zhu; Donggang Li; Junwei Li; Decai Wang
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

5.  Associations between Trace Elements and Cognitive Decline: An Exploratory 5-Year Follow-Up Study of an Elderly Cohort.

Authors:  Bianca Gerardo; Marina Cabral Pinto; Joana Nogueira; Paula Pinto; Agostinho Almeida; Edgar Pinto; Paula Marinho-Reis; Luísa Diniz; Paula I Moreira; Mário R Simões; Sandra Freitas
Journal:  Int J Environ Res Public Health       Date:  2020-08-20       Impact factor: 3.390

6.  Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment.

Authors:  J R Walton
Journal:  Int J Alzheimers Dis       Date:  2012-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.